Posted by admin on Aug 12th, 2022

Los Angeles Capital Management LLC decreased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 51.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,115 shares of the medical instruments supplier’s stock after selling 22,696 shares during the quarter. Los Angeles Capital Management LLC’s holdings in DENTSPLY SIRONA were worth $1,039,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of XRAY. Ceredex Value Advisors LLC grew its holdings in shares of DENTSPLY SIRONA by 147.6% during the fourth quarter. Ceredex Value Advisors LLC now owns 3,231,363 shares of the medical instruments supplier’s stock valued at $180,631,000 after buying an additional 1,926,113 shares in the last quarter. First Eagle Investment Management LLC grew its holdings in shares of DENTSPLY SIRONA by 16.5% during the fourth quarter. First Eagle Investment Management LLC now owns 7,184,012 shares of the medical instruments supplier’s stock valued at $400,796,000 after buying an additional 1,018,179 shares in the last quarter. Select Equity Group L.P. grew its holdings in shares of DENTSPLY SIRONA by 165.7% during the fourth quarter. Select Equity Group L.P. now owns 1,622,532 shares of the medical instruments supplier’s stock valued at $90,521,000 after buying an additional 1,011,929 shares in the last quarter. Cooke & Bieler LP boosted its position in DENTSPLY SIRONA by 37.1% during the fourth quarter. Cooke & Bieler LP now owns 3,525,683 shares of the medical instruments supplier’s stock valued at $196,698,000 after purchasing an additional 953,660 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its position in DENTSPLY SIRONA by 46.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,940,581 shares of the medical instruments supplier’s stock valued at $164,055,000 after purchasing an additional 936,681 shares during the last quarter. Hedge funds and other institutional investors own 94.79% of the company’s stock.

XRAY has been the subject of a number of research reports. Morgan Stanley reduced their price objective on DENTSPLY SIRONA from $48.00 to $44.00 and set an “overweight” rating for the company in a research report on Wednesday, July 20th. Bank of America cut DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $66.00 to $49.00 in a research report on Tuesday, April 19th. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Sunday, August 7th. The Goldman Sachs Group reduced their price target on DENTSPLY SIRONA from $42.00 to $41.00 and set a “neutral” rating for the company in a research report on Thursday, July 21st. Finally, Barrington Research reduced their price target on DENTSPLY SIRONA from $53.00 to $51.00 in a research report on Wednesday, May 11th. One analyst has rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average price target of $48.11.

Shares of XRAY opened at $37.17 on Friday. DENTSPLY SIRONA Inc. has a 12-month low of $33.78 and a 12-month high of $63.10. The company has a quick ratio of 1.03, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $8.01 billion, a price-to-earnings ratio of 21.99, a P/E/G ratio of 2.94 and a beta of 0.91. The stock’s 50-day moving average price is $36.31 and its 200 day moving average price is $43.50.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last issued its quarterly earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The firm had revenue of $9.67 billion for the quarter, compared to analyst estimates of $982.05 million. During the same period in the previous year, the company posted $0.72 earnings per share. The company’s quarterly revenue was up 841.1% compared to the same quarter last year. As a group, research analysts predict that DENTSPLY SIRONA Inc. will post 2.39 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Stockholders of record on Friday, September 30th will be paid a $0.125 dividend. The ex-dividend date of this dividend is Thursday, September 29th. This represents a $0.50 annualized dividend and a dividend yield of 1.35%. DENTSPLY SIRONA’s dividend payout ratio is currently 29.59%.

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating).

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC Purchases New Shares in Gevo, Inc. (NASDAQ:GEVO)